Blalock Williams, LLC Amgen Inc Transaction History

Blalock Williams, LLC

  • $114 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Nov 06, 2025
SELL
$262.28 - $309.85 $329,948 - $389,791
-1,258 Closed
0 $0
Q1 2025

Nov 06, 2025
BUY
$258.59 - $327.36 $96,712 - $122,432
374 Added 42.31%
1,258 $392 Million
Q4 2024

Nov 06, 2025
BUY
$258.78 - $328.31 $228,761 - $290,226
884 New
884 $230 Million

Others Institutions Holding AMGN

# of Institutions
3,273
Shares Held
428M
Call Options Held
6.11M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Blalock Williams, LLC Portfolio

Follow Blalock Williams, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blalock Williams, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blalock Williams, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email